tradmap

UPB Earnings Upstream Bio, Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$13 -$6 $0 2023 2024 2025
EPS
Revenue (annual)
$0 $1M $3M 2023 2024 2025
Revenue
Net income (annual)
-$143M -$72M $0 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$18 -$9 $0 Q3 '23 Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26
EPS
Revenue (quarterly)
$0 $517000 $1M Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Revenue
Net income (quarterly)
-$42M -$21M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income

Reported EPS history

1–12 of 12
Q2 20262026-06-30-1.472026-08-1110-Q
Q1 20262026-03-31-0.752026-05-1310-Q
FY 20252025-12-31-2.662026-03-2610-K
Q3 20252025-09-30-1.882025-11-0510-Q
Q2 20262025-06-30-1.252026-08-1110-Q
Q1 20262025-03-31-0.512026-05-1310-Q
FY 20252024-12-31-5.582026-03-2610-K
Q3 20252024-09-30-18.152025-11-0510-Q
Q2 20252024-06-30-11.182025-08-0610-Q
Q1 20252024-03-31-4.682025-05-0610-Q
FY 20242023-12-31-12.952025-03-1210-K
Q3 20242023-09-30-7.902024-11-0710-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.